Literature DB >> 16840421

Anticoagulant therapy and idiopathic pulmonary fibrosis.

Brent W Kinder, Harold R Collard, Talmadge E King.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16840421     DOI： 10.1378/chest.130.1.302-a

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

Review 1.  Acute exacerbations of idiopathic pulmonary fibrosis.

Authors:  Harold R Collard; Bethany B Moore; Kevin R Flaherty; Kevin K Brown; Robert J Kaner; Talmadge E King; Joseph A Lasky; James E Loyd; Imre Noth; Mitchell A Olman; Ganesh Raghu; Jesse Roman; Jay H Ryu; David A Zisman; Gary W Hunninghake; Thomas V Colby; Jim J Egan; David M Hansell; Takeshi Johkoh; Naftali Kaminski; Dong Soon Kim; Yasuhiro Kondoh; David A Lynch; Joachim Müller-Quernheim; Jeffrey L Myers; Andrew G Nicholson; Moisés Selman; Galen B Toews; Athol U Wells; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2007-06-21       Impact factor: 21.405

2.  [Clinical significance of hypersensitive C-reactive protein, fribrinogen and D-dimmer in connective tissue disease-related interstitial lung disease].

Authors:  Si-Jie Yuan; Hai-Ting Xie; Zhong-Li Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-03-20

3.  Diffuse alveolar hemorrhage in coumarin users: a fibrosing interstitial pneumonia trigger?

Authors:  Petal A Wijnen; Johny A Verschakelen; Aalt Bast; Otto Bekers; Marjolein Drent
Journal:  Lung       Date:  2012-11-13       Impact factor: 2.584

4.  Alterations in cytoskeletal and immune function-related proteome profiles in whole rat lung following intratracheal instillation of heparin.

Authors:  Amir A Gabr; Mathew Reed; Donna R Newman; Jan Pohl; Jody Khosla; Philip L Sannes
Journal:  Respir Res       Date:  2007-05-08

Review 5.  Managing comorbidities in idiopathic pulmonary fibrosis.

Authors:  Blair G Fulton; Christopher J Ryerson
Journal:  Int J Gen Med       Date:  2015-09-22

6.  Associations of Serological Biomarkers of sICAM-1, IL-1β, MIF, and su-PAR with 3-Month Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.

Authors:  Xuran Li; Ying Zhou; Ruyi Zou; Haoran Chen; Xiaoqin Liu; Xiaohua Qiu; Yonglong Xiao; Hourong Cai; Jinghong Dai
Journal:  Mediators Inflamm       Date:  2020-07-06       Impact factor: 4.711
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.